PropertyValue
?:abstract
  • There are limited data on the use of extracorporeal membrane oxygenation (ECMO) for pregnant and peripartum women with COVID-19 associated acute respiratory distress syndrome (ARDS). Pregnant women may exhibit more severe infections with COVID-19, requiring intensive care. We supported nine pregnant or peripartum women with COVID-19 ARDS with ECMO, all surviving and suffering no major complications from ECMO. Our case series demonstrates high-maternal survival rates with ECMO support in the management of COVID-19 associated severe ARDS, highlighting that these pregnant and postpartum patients should be supported with ECMO during this pandemic.
is ?:annotates of
?:creator
?:doi
?:doi
  • 10.1097/mat.0000000000001357
?:journal
  • ASAIO_J
?:license
  • no-cc
?:pdf_json_files
  • document_parses/pdf_json/c29f2f4cf36f0951794148d3ba616ba415443ce6.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7846250.xml.json
?:pmcid
?:pmid
?:pmid
  • 33229971.0
?:publication_isRelatedTo_Disease
?:sha_id
?:source
  • Medline; PMC
?:title
  • Successful Treatment of Pregnant and Postpartum Women With Severe COVID-19 Associated Acute Respiratory Distress Syndrome With Extracorporeal Membrane Oxygenation
?:type
?:year
  • 2020-11-20

Metadata

Anon_0  
expand all